Cincinnati

Trepp Announces The Winners of Inaugural Scholarship Award

Retrieved on: 
Thursday, May 25, 2023
Learning, 9/11 Family Steering Committee, Bachelor of Science in Information Technology, University, University of Cincinnati Academic Health Center, Parent, Scholarship, New York University, Real estate, Student, Committee, Commission on Industrial Relations, The Pacific Sociological Association Distinguished Scholarship Award, Cincinnati, CRE, Milan Timko, Forestry, Nursing, Science, Trepp

NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award. Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.

Key Points: 
  • Trepp has announced Jack Walsh of the University of Cincinnati and Mohammed Wara of New York University – Schack Institute of Real Estate, the winners of the inaugural 2023 Trepp Education Scholarship Award.
  • NEW YORK, May 25, 2023 /PRNewswire-PRWeb/ -- Trepp, a leading provider Trepp, a leading provider of data, insights, and technology solutions to structured finance, commercial real estate, and banking markets, announced today the winner of its 2023 Scholarship Award.
  • Trepp awarded John "Jack" Walsh, a rising senior studying to earn a bachelor's in business administration with a focus in Finance, and Real Estate from the University of Cincinnati's Carl H. Linder College of Business, the $10,000 Trepp Scholarship Award, to go toward tuition assistance.
  • More than 50 applicants applied for the scholarship, leaving an arduous task to the Trepp Education Steering Committee to narrow down to six finalists.

First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center

Retrieved on: 
Thursday, May 11, 2023
Male, Radiation, Surgeon, AIM, Pulmonology, Research, Ventilation, MRI, Hospital, Magnetic resonance imaging, Patient, Cystic fibrosis, Lahey Hospital & Medical Center, Ageing, Cincinnati, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Disease, Medical imaging

Durham, N.C. , May 11, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM:POLX), the medical imaging company, announces that the first clinical scan utilising its XENOVIEW (xenon Xe 129 hyperpolarized) technology in the United States has taken place at Cincinnati Children’s Hospital Medical Center (“Cincinnati Children’s”).

Key Points: 
  • Durham, N.C. , May 11, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM:POLX), the medical imaging company, announces that the first clinical scan utilising its XENOVIEW (xenon Xe 129 hyperpolarized) technology in the United States has taken place at Cincinnati Children’s Hospital Medical Center (“Cincinnati Children’s”).
  • The first patient to receive a clinical scan using XENOVIEW is a 19-year-old male with cystic fibrosis.
  • Cincinnati Children’s has several other patients it believes are medically indicated for the lung imaging XENOVIEW provides and anticipates performing scans to monitor patients on a more regular basis.
  • Richard Hullihen, CEO of Polarean, said: “The first clinical scan in the United States is a significant milestone for Polarean and the XENOVIEW technology.

Cincinnati Financial Corporation Holds Shareholders' and Directors' Meetings

Retrieved on: 
Monday, May 8, 2023
Fleming Companies, Inc, Cincinnati Financial, CINF, CPCU, CPA, Cincinnati, Management

CINCINNATI, Ohio, May 8, 2023 /PRNewswire/ -- Cincinnati Financial Corporation (Nasdaq: CINF) today announced that based on preliminary voting results at the company's annual meeting on May 6, 2023, shareholders elected all directors for one-year terms to the 12-member board.

Key Points: 
  • CINCINNATI, Ohio, May 8, 2023 /PRNewswire/ -- Cincinnati Financial Corporation (Nasdaq: CINF) today announced that based on preliminary voting results at the company's annual meeting on May 6, 2023, shareholders elected all directors for one-year terms to the 12-member board.
  • The board of directors elected officers at its regularly scheduled meeting following the annual meeting, including the election of Steven A. Soloria as chief investment officer and executive vice president of Cincinnati Financial Corporation.
  • Our highly engaged group of directors brings diversity of thought and experience to guide long-term strategic plans for Cincinnati Financial Corporation, as we work to create increasing value for shareholders."
  • The board also announced committee service for the coming year, in line with the independence requirements of applicable law and the listing standards of Nasdaq:

Regis Corporation Appoints Nancy Benacci to Its Board of Directors

Retrieved on: 
Wednesday, May 3, 2023
Cosmetics, Men, Retail, Family, Consumer, Other Retail, Bridal, Parenting, LGBTQ+, Other Consumer, Specialty, Women, Seniors, Fashion, CFA, Cincinnati Financial, Audit, Research, KeyBank, RGS, CINF, Retirement, Corporation, National City Bank, Certification, Eaton Corporation, Regis Corporation, National Association, Cincinnati, NYSE, Management

Regis Corporation (NYSE:RGS), a leader in the haircare industry, today announces the appointment of Nancy Benacci to its Board of Directors, effective May 1, 2023.

Key Points: 
  • Regis Corporation (NYSE:RGS), a leader in the haircare industry, today announces the appointment of Nancy Benacci to its Board of Directors, effective May 1, 2023.
  • She directed a sell-side equity research group of more than 100 individuals covering 600 public companies in a variety of industries.
  • David Grissen, Chairman, stated, “I am excited Nancy is joining the Regis Board of Directors.
  • Nancy will make an excellent addition to our Audit Committee.”
    Upon retiring from a long and successful 31-year career at KeyBanc, Ms. Benacci joined the Board of Directors of Cincinnati Financial Corp. (NASDAQ: CINF).

Philadelphia Phillies Choose Evolv as Preferred Fan Screening Provider

Retrieved on: 
Thursday, April 6, 2023
Baseball, Sports, Data Analytics, Hardware, Artificial Intelligence, Professional Services, Technology, Security, Weapon, NFL, Partnership, Evolve Tag Team Championship, Philadelphia Phillies, Citizens Bank Park, Cincinnati Reds, Cincinnati, National League, Mercedes-Benz Stadium, Major League, Sport, Artificial intelligence, AI, SoFi Stadium, Citi Field

Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, today announced its partnership with the defending National League champion Philadelphia Phillies.

Key Points: 
  • Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, today announced its partnership with the defending National League champion Philadelphia Phillies.
  • Citizens Bank Park will feature Evolv’s state-of-the-art Evolv Express® screening solution beginning with the Phillies’ home opener on April 7, when they host the Cincinnati Reds.
  • Citizens Bank Park is the third Philadelphia pro sports venue to implement Evolv.
  • “This is an exciting time for Evolv to partner with the Phillies,” said John Baier, Evolv’s vice president of sports.

Scioto Biosciences Announces Publication of Phase 1b Study in Autism

Retrieved on: 
Monday, April 3, 2023
Research, General Health, Pharmaceutical, Family, Consumer, Mental Health, Parenting, Children, Clinical Trials, Science, Biotechnology, Health, LR, Meredith, Therapy, Prevalence, Social, Spectrum, Centers for Disease Control and Prevention timeline, Hope, Oxytocin, Limosilactobacillus reuteri, Doctor of Philosophy, CDC, MD, Patient, ASD, Randomized controlled trial, Scientific Reports, Paper, Hospital, Bacteria, Cincinnati, Autism spectrum, Safety, Nature Portfolio, Pharmaceutical industry, Management

Scioto Biosciences Inc., (the “Company” or “Scioto Biosciences”) a clinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced the publication of results from a Phase 1b study of their lead product SB-121 in patients with Autistic Spectrum Disorder (ASD).

Key Points: 
  • Scioto Biosciences Inc., (the “Company” or “Scioto Biosciences”) a clinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced the publication of results from a Phase 1b study of their lead product SB-121 in patients with Autistic Spectrum Disorder (ASD).
  • The publication, Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder , was published in the journal Scientific Reports.
  • Scientific Reports, a part of Nature Publishing, is an open access journal requiring a rigorous peer-review process prior to publication.
  • The first-in-human study was double-blind, placebo controlled, 28-day crossover study of the safety and tolerability of SB-121.

Three New Members Added to Board of Directors

Retrieved on: 
Wednesday, April 12, 2023
Area studies, University, College, Executive director, FAIA, Johns Hopkins University, Maryland Department of Public Safety and Correctional Services, CHAP, Ashley, Risk management, Raleigh, North Carolina, Research, CJE, History, K-12, Baltimore, Architect, School, Maryland Department of Planning, College of Fellows of the American Theatre, North Carolina State University, Cincinnati, AIA, History of virtual learning environments in the 1990s, Financial adviser, Management, Architecture

RICHMOND, Va., April 12, 2023 /PRNewswire/ -- K-12 Principal Ashley Dennis, AIA, is the youngest person ever elected to the board. Since joining Moseley Architects in 2008, Ashley has amassed a portfolio of 47 projects for public school system clients throughout North Carolina. Under her management since 2017, the firm's Raleigh office has grown exponentially: the staff size has doubled, the number of K-12 clients has nearly tripled, and the annual revenue has averaged $3.3 million. In 2022, she served as president of the North Carolina chapter of the Association of Learning Environments. Ashley is a graduate of North Carolina State University's School of Architecture.

Key Points: 
  • Moseley Architects' shareholders elected three new members to its board of directors.
  • RICHMOND, Va., April 12, 2023 /PRNewswire/ -- K-12 Principal Ashley Dennis, AIA, is the youngest person ever elected to the board.
  • Since joining Moseley Architects in 2008, Ashley has amassed a portfolio of 47 projects for public school system clients throughout North Carolina.
  • Dan Mace, AIA, and Magda Westerhout, AIA, retired from the board, but remain active as principals and leaders in the firm.

NOVARC TECHNOLOGIES ANNOUNCES APPOINTMENT OF CHRISTINE BOLES TO BOARD OF DIRECTORS

Retrieved on: 
Wednesday, March 22, 2023
University, Boles, Internet, University of Cincinnati, Arizona State Capitol, MBA, EDGE Group, NEX, Arizona State University, Knowledge, Ecosystem, AI, Robotics, Cincinnati, Woman, Electricity, 3D printing, Management, Science

VANCOUVER, CANADA, March 22, 2023 (GLOBE NEWSWIRE) -- Novarc Technologies Inc. (“Novarc”), a full-stack robotics company specializing in the design and commercialization of collaborative robots (“cobots”) and AI systems for robotic welding applications, today announced the appointment of Christine Boles to the Novarc’ Board of Directors.

Key Points: 
  • VANCOUVER, CANADA, March 22, 2023 (GLOBE NEWSWIRE) -- Novarc Technologies Inc. (“Novarc”), a full-stack robotics company specializing in the design and commercialization of collaborative robots (“cobots”) and AI systems for robotic welding applications, today announced the appointment of Christine Boles to the Novarc’ Board of Directors.
  • "We are thrilled to welcome Christine Boles to our board of directors,” said Hamid Abdollahi, Chairman of Novarc Technologies’ Board of Directors.
  • “I am excited to join the Novarc Technologies’ Board of Directors to support their business goals with their innovative full stack robotics solutions to a range of industries,” said Christine Boles.
  • Boles serves as a member of the Arizona Technology Council Board of Directors where she brings her passion for technology to Arizona’s tech industry community.

Warren County, altafiber announce fiber partnership

Retrieved on: 
Tuesday, March 21, 2023
Technology, Mobile, Wireless, Internet, Telecommunications, Amalgamation, Cincinnati metropolitan area, Partnership, Quality of life, County, Warren, Cincinnati, Internet access

Warren County and altafiber have announced a new partnership that will bring gigabit high-speed broadband fiber Internet access to approximately 52,000 addresses over the next 36-48 months.

Key Points: 
  • Warren County and altafiber have announced a new partnership that will bring gigabit high-speed broadband fiber Internet access to approximately 52,000 addresses over the next 36-48 months.
  • Upon completion of the project, 100 percent of Warren County’s single-family residences will have access to fiber-based Internet.
  • Warren County’s Board of County Commissioners have approved an additional $4.8 million of American Rescue Plan Act funding to support the project.
  • altafiber is the leading supplier of fiber-based services in Greater Cincinnati and has invested more than $1.5 billion into expanding its fiber network across the region.

Gamida Cell Announces Changes to Board of Directors

Retrieved on: 
Monday, March 20, 2023
Science, Stem Cells, Biotechnology, Research, Pharmaceutical, Oncology, Health, FDA, Gilead Sciences, University, Therapy, Parliamentary Information Technology Committee, Marketing, Chief commercial officer, Non-Hodgkin lymphoma, Audit committee, Shawn, MBA, Cell, Pharmacyclics, Acquisition, Patient, AbbVie, Kite Pharma, Cincinnati, Science and Technology Committee (House of Lords), Murray State University, Pharmaceutical industry

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the resignation of Chairman Robert I. Blum.

Key Points: 
  • Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the resignation of Chairman Robert I. Blum.
  • “On behalf of my fellow board members and Gamida Cell’s employees, I want to thank Robert for his dedicated service to this company,” said Abbey Jenkins, Gamida Cell President and Chief Executive Officer.
  • “Robert has been a tireless advocate for Gamida Cell for the past five years and has provided strong oversight through many critical decisions.
  • “Gamida Cell is at an inflection point, with the potential FDA approval of omidubicel in the near term.